Search Results - "Marinho, Rui T"

Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: a prospective study by Noronha Ferreira, Carlos, Marinho, Rui, Cortez-Pinto, Helena, Ferreira, Paula, Dias, Margarida S., Vasconcelos, Mariana, Alexandrino, Paula, Serejo, Maria de Fátima, Pedro, Ana Júlia, Gonçalves, Afonso, Palma, Sónia, Leite, Inês, Reis, Daniela, Damião, Filipe, Valente, Ana, Xavier Brito, Leonor, Baldaia, Cilenia, Fatela, Narcisa, Ramalho, Fernando Jorge Martins, Velosa, José

“…© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. Background and aims: The role of portal vein thrombosis (PVT) in the natural history of…”
Get full text

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel by Cornberg, Markus, Razavi, Homie A., Alberti, Alfredo, Bernasconi, Enos, Buti, Maria, Cooper, Curtis, Dalgard, Olav, Dillion, John F., Flisiak, Robert, Forns, Xavier, Frankova, Sona, Goldis, Adrian, Goulis, Ioannis, Halota, Waldemar, Hunyady, Bela, Lagging, Martin, Largen, Angela, Makara, Michael, Manolakopoulos, Spilios, Marcellin, Patrick, Marinho, Rui T., Pol, Stanislas, Poynard, Thierry, Puoti, Massimo, Sagalova, Olga, Sibbel, Scott, Simon, Krzysztof, Wallace, Carolyn, Young, Kendra, Yurdaydin, Cihan, Zuckerman, Eli, Negro, Francesco, Zeuzem, Stefan

“…Background and Aim: Decisions on public health issues are dependent on reliable epidemiological data. A comprehensive review of the literature was used to…”
Get full text

Mortality Associated with Hepatobiliary Disease in Portugal between 2006 and 2012 by da Rocha, Manuel Coelho, Marinho, Rui T., Rodrigues, Teresa

“…Introduction: Hepatobiliary disease is becoming a major public health problem, and recent data suggest that the burden of liver disease is higher than…”
Get full text

Benefits of curing hepatitis C infection by Marinho, Rui T, Vitor, Sofia, Velosa, Jose

“…The hepatitis C virus (HCV) infection is one of the most important chronic viral infections worldwide and affects 3% of the world population, approximately…”
Get full text

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV by Ferenci, Peter, Bernstein, David, Lalezari, Jacob, Cohen, Daniel, Luo, Yan, Cooper, Curtis, Tam, Edward, Marinho, Rui T, Tsai, Naoky, Nyberg, Anders, Box, Terry D, Younes, Ziad, Enayati, Pedram, Green, Sinikka, Baruch, Yaacov, Bhandari, Bal Raj, Caruntu, Florin Alexandru, Sepe, Thomas, Chulanov, Vladimir, Janczewska, Ewa, Rizzardini, Giuliano, Gervain, Judit, Planas, Ramon, Moreno, Christophe, Hassanein, Tarek, Xie, Wangang, King, Martin, Podsadecki, Thomas, Reddy, K. Rajender

“…Among previously untreated patients with HCV genotype 1 infection, three new antiviral agents, with or without ribavirin, resulted in high rates of sustained…”
Get full text

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin by Zeuzem, Stefan, Jacobson, Ira M, Baykal, Tolga, Marinho, Rui T, Poordad, Fred, Bourlière, Marc, Sulkowski, Mark S, Wedemeyer, Heiner, Tam, Edward, Desmond, Paul, Jensen, Donald M, Di Bisceglie, Adrian M, Varunok, Peter, Hassanein, Tarek, Xiong, Junyuan, Pilot-Matias, Tami, DaSilva-Tillmann, Barbara, Larsen, Lois, Podsadecki, Thomas, Bernstein, Barry

“…In this trial in patients with HCV genotype 1 infection and no cirrhosis who had previously been treated with peginterferon and ribavirin, retreatment with…”
Get full text

The burden of alcoholism in fifteen years of cirrhosis hospital admissions in Portugal by Marinho, Rui T., Duarte, Henrique, Gíria, José, Nunes, Joana, Ferreira, Alexandre, Velosa, José

“…Background & Aims Deploying a longitudinal perspective, we observe how cirrhosis caused mortality rates in Portugal are converging with the levels reported in…”
Get full text

High SVR Rates with Eight and Twelve Weeks of Pangenotypic Glecaprevir/Pibrentasvir: Integrated Efficacy Analysis of Genotype 1-6 Patients Without Cirrhosis by Puoti, Massimo, Foster, Graham R, Wang, Stanley, Mutimer, David J, Gane, Edward, Moreno, Christophe, Chang, Ting Tsung, Lee, Sam, Marinho, Rui T, DuFour, Jean-Francois, Pol, Stanislas, Hezode, Christophe, Gordon, Stuart C, Strasser, Simone I, Thuluvath, Paul J, Liu, Ran, Pilot-Matias, Tami, Mensa, Federico

Get full text

Su1422 Efficacy and Safety of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir Without Ribavirin in Patients with HCV Genotype 1b With or Without Compensated Cirrhosis: Pooled Analysis Across 5 Clinical Trials by Welzel, Tania M, Isakov, Vasily, Trinh, Roger N, Streinu-Cercel, Adrian, Dufour, Jean-Francois, Marinho, Rui T, Moreno, Christophe, Liu, Li, Xie, Wangang, Tatsch, Fernando, Shulman, Nancy S, Craxì, Antonio

Get full text

235 SAPPHIRE II: Phase 3 Placebo-Controlled Study of Interferon-Free, 12-Week Regimen of ABT-450/r/ABT-267, ABT-333, and Ribavirin in 394 Treatment-Experienced Adults With Hepatitis C Virus Genotype 1 by Jacobson, Ira M, Zeuzem, Stefan, Baykal, Tolga, Marinho, Rui T, Poordad, Fred, Bourliere, Marc, Sulkowski, Mark, Wedemeyer, Heiner, Tam, Edward, Desmond, Paul V, Jensen, Donald M, Di Bisceglie, Adrian M, Varunok, Peter, Hassanein, Tarek, Xiong, Junyuan, DaSilva-Tillmann, Barbara, Larsen, Lois, Podsadecki, Thomas

Get full text

Lymphocyte T helper-specific reactivity in sustained responders to interferon and ribavirin with negativation (seroreversion) of anti-hepatitis C virus by Marinho, Rui T., Pinto, Ruth M., Santos, Maria L., De Moura, Miguel Carneiro

“…© Blackwell Munksgaard 2004 Background: Seroreversion, negativation of anti-hepatitis C virus previously positive, is sometimes found in some chronic hepatitis…”
Get full text

EP1288: TRANSMURAL REMISSION IMPROVES CLINICAL OUTCOMES UP TO 5 YEARS IN PATIENTS WITH CROHN'S DISEASE by Serrazina, Juliana, Botto, Inês, Fernandes, Samuel R., Garcia, Joana Lemos, Neves, João A. Cunha, Campelo, Pedro, Carvalho, Diana, Bernardo, Sónia, Gonçalves, Ana R., Valente, Ana, Moura-Santos, Paula, Rosa, Isadora, Sousa, Helena Tavares, Ramos, Jaime, Venâncio, José M., Leitão, João, Claro, Isabel, Correia, Luís Araujo, Marinho, Rui T.

Get full text

Tu1820 – Proactive Infliximab Drug Monitoring is Superior to Conventional Management in Inflammatory Bowel Disease by Fernandes, Samuel R., Bernardo, Sónia, Simões, Carolina, Correia, Luís Araujo, Moura-Santos, Paula, Gonçalves, Ana R., Valente, Ana, Baldaia, Cilénia, Marinho, Rui T.

Get full text

Oropharyngeal pemphigus in a patient with chronic hepatitis C during interferon alpha-2a therapy by MARINHO, Rui T, JOHNSON, Newell W, FATELA, Narcisa M, SEREJO, Fatima S, GLORIA, Helena, RAIMUNDO, Miguel O, VELOSA, José F, RAMALHO, Fernando J, MOURA, Miguel C

“…There are a few reports in the literature concerning pemphigus induced by interferon given for hepatitis C. We present the case of a 28-year-old woman with…”
Get full text

Tu1578 – Anticoagulation in Patients with Cirrhosis and Portal Vein Thrombosis is Associated with Better Prognosis in Advanced Cirrhosis by Ferreira, Carlos Noronha, Reis, Daniela, Cortez-Pinto, Helena, Marinho, Rui T., Gonçalves, Afonso, Palma, Sonia, Leite, Inês, Rodrigues, Tiago, Pedro, Ana Júlia, Alexandrino, Paula T., Serejo, Fátima, Dias, Margarida Sobral, Ferreira, Paula, Vasconcelos, Mariana, Damiao, Filipe, Brito, Leonor Xavier, Baldaia, Cilenia, Fatela, Narcisa, Ramalho, Fernando, Velosa, José

Get full text

Hepatitis B Vaccination in Hospital Personnel and Medical Students by Marinho, Rui T, Moura, Miguel C, Pedro, Marília, Ramalho, Fernando J, Velosa, José F

“…We determined the prevalence of hepatitis B markers and the compliance to hepatitis B vaccination in a University Hospital of Santa Maria, Lisbon. The program…”
Get full text

The burden of alcoholism in fifteen years of cirrhosis hospital admissions in P ortugal by Marinho, Rui T., Duarte, Henrique, Gíria, José, Nunes, Joana, Ferreira, Alexandre, Velosa, José

“…Abstract Background & Aims Deploying a longitudinal perspective, we observe how cirrhosis caused mortality rates in P ortugal are converging with the levels…”
Get full text

The changing epidemiological pattern of hepatitis A in Lisbon, Portugal by Marinho, R T, Valente, A R, Ramalho, F J, de Moura, M C

“…To evaluate the prevalence of anti-hepatitis A virus (HAV) in an urban population, in order to assess the changing epidemiological pattern of hepatitis A. We…”
Get more information

429 - High SVR Rates with Eight and Twelve Weeks of Pangenotypic Glecaprevir/Pibrentasvir: Integrated Efficacy Analysis of Genotype 1-6 Patients Without Cirrhosis by Puoti, Massimo, Foster, Graham R., Wang, Stanley, Mutimer, David J., Gane, Edward, Moreno, Christophe, Chang, Ting Tsung, Lee, Sam, Marinho, Rui T., DuFour, Jean-Francois, Pol, Stanislas, Hezode, Christophe, Gordon, Stuart C., Strasser, Simone I., Thuluvath, Paul J., Liu, Ran, Pilot-Matias, Tami, Mensa, Federico

Get full text

ABT-450/r-Ombitasvir and Dasabuvir with or without Ribavirin for HCV by FERENCI, Peter, BERNSTEIN, David, BOX, Terry D, YOUNES, Ziad, ENAYATI, Pedram, GREEN, Sinikka, BARUCH, Yaacov, BAL RAJ BHANDARI, CARUNTU, Florin Alexandru, SEPE, Thomas, CHULANOV, Vladimir, JANCZEWSKA, Ewa, LALEZARI, Jacob, RIZZARDINI, Giuliano, GERVAIN, Judit, PLANAS, Ramon, MORENO, Christophe, HASSANEIN, Tarek, WANGANG XIE, KING, Martin, PODSADECKI, Thomas, RAJENDER REDDY, K, COHEN, Daniel, YAN LUO, COOPER, Curtis, TAM, Edward, MARINHO, Rui T, TSAI, Naoky, NYBERG, Anders

Get full text